Compare FIBK & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FIBK | HAE |
|---|---|---|
| Founded | 1879 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.8B |
| IPO Year | 1997 | 1996 |
| Metric | FIBK | HAE |
|---|---|---|
| Price | $38.45 | $84.81 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 9 |
| Target Price | $35.63 | ★ $84.13 |
| AVG Volume (30 Days) | ★ 1.2M | 605.4K |
| Earning Date | 04-29-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.46% | N/A |
| EPS Growth | ★ 34.25 | N/A |
| EPS | 0.61 | ★ 2.05 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.91 | $5.23 |
| P/E Ratio | $61.89 | ★ $41.67 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.60 | $47.32 |
| 52 Week High | $40.60 | $87.32 |
| Indicator | FIBK | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 75.48 |
| Support Level | $35.49 | $78.87 |
| Resistance Level | $37.82 | $86.72 |
| Average True Range (ATR) | 0.80 | 2.40 |
| MACD | -0.26 | 0.49 |
| Stochastic Oscillator | 6.86 | 97.68 |
First Interstate BancSystem Inc is a financial holding company. It is the parent company of First Interstate Bank, a community bank offering a range of internet, mobile, and other banking and financial services throughout Idaho, Montana, Oregon, South Dakota, Washington, and Wyoming. It delivers a range of financial products and services to both retail and commercial customers in industries like agriculture, construction, education, energy, governmental services, healthcare, mining, professional services, retail, tourism and wholesale trade. It generates majority of income from interest charged on loans, and interest and dividends earned on investments.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.